Transdiagnostic Group Treatments for Patients With Common Mental Disorders in Primary Health Care

Sponsor
Karolinska Institutet (Other)
Overall Status
Completed
CT.gov ID
NCT01565213
Collaborator
(none)
245
1
3
56
4.4

Study Details

Study Description

Brief Summary

The purpose of this study is to compare the effects of CBT and MMI on the quality of life and relief of psychological symptoms of patients with common mental disorders or problems attending primary health care centre.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: CBT
  • Behavioral: MMI
  • Behavioral: CAU
Phase 3

Detailed Description

Design:

Clinical randomised non blinded controlled trial.

Setting:

The study was performed in an outpatient primary health care centre serving 36 000 inhabitants.

Participants:

Patients (n=278), aged 18-65 years, with common mental problems or disorders were referred to the study by the GPs and 245 were included in the study.

Interventions:

Participants were randomised to CAU or one of two group interventions in addition to CAU. These were: a) group cognitive behavioural based therapy (CBT) administered by psychologists once a week for 12 weeks, and b) group multimodal intervention (MMI) based on a protocol comprising a mix of existing group interventions and exercises borrowed from multiple techniques and therapeutic schools and administered by assistant nurses with brief training, including two sessions per week for 6 weeks.

Main outcome measures:

Primary outcome measure was the Mental Component Summary score of SF-36. Secondary outcome measures were perceived stress scale (PSS) and Self-Rating Scale for Affective Syndromes (CPRS-S-A)

Study Design

Study Type:
Interventional
Actual Enrollment :
245 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Transdiagnostic Group Treatments for Patients With Common Mental Disorders in Primary Health Care: A Randomized Controlled Trial
Study Start Date :
Jan 1, 2006
Actual Primary Completion Date :
Sep 1, 2008
Actual Study Completion Date :
Sep 1, 2010

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: CBT cognitive behavioral therapy

group cognitive behavioural based therapy (CBT) administered by psychologists once a week for 12 weeks

Behavioral: CBT
group cognitive behavioural based therapy (CBT) administered by psychologists once a week for 12 weeks,

Active Comparator: MMI Multimodal group intervention

group multimodal intervention

Behavioral: MMI
group multimodal intervention (MMI) based on a protocol comprising a mix of existing group interventions and exercises borrowed from multiple techniques and therapeutic schools and administered by assistant nurses with brief training, including two sessions per week for 6 weeks.

Other: CAU

Care as usual given by the GPs

Behavioral: CAU
Care as usual by the GPs

Outcome Measures

Primary Outcome Measures

  1. Change in Quality of life as measured by the SF-36 (Mental Component Score) [Change from baseline in SF-36 at 52 weeks]

Secondary Outcome Measures

  1. Change in Psychopathology as measured by the Comprehensive Psychopathological Rating Scale Self-asssessmen (CPRS-S-A) [Change from baseline in CPRS-S-A at weeks 52]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • patients with common mental disorders or problems
Exclusion Criteria:

patients were excluded if:

  • they met diagnostic criteria for bipolar or psychotic disorder or severe personality disorder,

  • were judged to be at risk of committing suicidal acts, and

  • if they had undergone MMI earlier. The investigators paid no consideration to whether patients were treated with SSRI medication.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Center for Family and Community Medicine, Karolinska Institutet, Huddinge Sweden 141 83

Sponsors and Collaborators

  • Karolinska Institutet

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Kersti Ejeby, MD Head GP, Karolinska Institutet
ClinicalTrials.gov Identifier:
NCT01565213
Other Study ID Numbers:
  • LS 0506-1010
First Posted:
Mar 28, 2012
Last Update Posted:
Mar 28, 2012
Last Verified:
Mar 1, 2012
Keywords provided by Kersti Ejeby, MD Head GP, Karolinska Institutet
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 28, 2012